Anavex Life Sciences (AVXL) Other Working Capital Changes (2010 - 2025)
Anavex Life Sciences recorded quarterly Other Working Capital Changes of -$33000.0 in Q4 2025, down 73.68% quarter-over-quarter from -$19000.0 in Q3 2025, and up 85.0% year-over-year from -$17837.8 in Q4 2024.
Anavex Life Sciences' Other Working Capital Changes history runs 16 years deep, the most recent figure standing at -$33000.0 for Q4 2025.
- In Q4 2025, Other Working Capital Changes rose 85.0% year-over-year to -$33000.0; the TTM figure through Dec 2025 stood at -$315000.0 (down 600.0% YoY), while the FY2025 annual figure was -$502000.0, down 280.58% from the prior year.
- Other Working Capital Changes came in at -$33000.0 for Q4 2025 at Anavex Life Sciences, down from -$19000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $589000.0 in Q1 2024 to a low of -$286000.0 in Q2 2024.
- A 5-year average of -$100.05 and a median of -$15515.5 in 2021 frame the typical range for Other Working Capital Changes.
- Across the five-year window, Other Working Capital Changes soared 1249.11% in 2022 and plunged 5766.77% in 2023, its largest moves.
- Anavex Life Sciences' Other Working Capital Changes stood at $22311.0 in 2021, then jumped by 1249.11% to $301000.0 in 2022, then sank by 65.78% to $103000.0 in 2023, then sank by 313.59% to -$220000.0 in 2024, then surged by 85.0% to -$33000.0 in 2025.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$33000.0, -$19000.0, and -$254000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Anavex Life Sciences | 266.20 Mn | 134.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -33,000.00 |
| Dec 31, 2025 | -33,000.00 |
| Sep 30, 2025 | -19,000.00 |
| Sep 30, 2025 | -19,000.00 |
| Jun 30, 2025 | -254,000.00 |
| Jun 30, 2025 | -254,000.00 |
| Mar 31, 2025 | -9,000.00 |
| Mar 31, 2025 | -9,000.00 |
| Dec 31, 2024 | -220,000.00 |
| Dec 31, 2024 | -220,000.00 |
| Sep 30, 2024 | -128,000.00 |
| Sep 30, 2024 | -128,000.00 |
| Jun 30, 2024 | -286,000.00 |
| Jun 30, 2024 | -286,000.00 |
| Mar 31, 2024 | 589,000.00 |
| Mar 31, 2024 | 589,000.00 |
| Dec 31, 2023 | 103,000.00 |
| Dec 31, 2023 | 103,000.00 |
| Sep 30, 2023 | -174,000.00 |
| Sep 30, 2023 | -174,000.00 |
| Jun 30, 2023 | -155,000.00 |
| Jun 30, 2023 | -155,000.00 |
| Mar 31, 2023 | 327,000.00 |
| Mar 31, 2023 | 327,000.00 |
| Dec 31, 2022 | 301,000.00 |
| Dec 31, 2022 | 301,000.00 |
| Sep 30, 2022 | -107,414.00 |
| Sep 30, 2022 | -107,414.00 |
| Jun 30, 2022 | -2,642.00 |
| Jun 30, 2022 | -2,642.00 |
| Mar 31, 2022 | 86,745.00 |
| Mar 31, 2022 | 86,745.00 |
| Dec 31, 2021 | 22,311.00 |
| Dec 31, 2021 | 22,311.00 |
| Sep 30, 2021 | 97,641.00 |
| Sep 30, 2021 | 97,641.00 |
| Jun 30, 2021 | -128,611.00 |
| Jun 30, 2021 | -128,611.00 |
| Mar 31, 2021 | -12,031.00 |
| Mar 31, 2021 | -12,031.00 |
| Dec 31, 2020 | -44,999.00 |
| Dec 31, 2020 | -44,999.00 |
| Sep 30, 2020 | -57,159.00 |
| Sep 30, 2020 | -57,159.00 |
| Jun 30, 2020 | 195,439.00 |
| Jun 30, 2020 | 195,439.00 |
| Mar 31, 2020 | 70,587.00 |
| Mar 31, 2020 | 70,587.00 |
| Dec 31, 2019 | -266,026.00 |
| Dec 31, 2019 | -266,026.00 |
| Sep 30, 2019 | 26,380.00 |
| Sep 30, 2019 | 26,380.00 |
| Jun 30, 2019 | -390,024.00 |
| Jun 30, 2019 | -390,024.00 |
| Mar 31, 2019 | -334,363.00 |
| Mar 31, 2019 | -334,363.00 |
| Dec 31, 2018 | -105,189.00 |
| Dec 31, 2018 | -105,189.00 |
| Sep 30, 2018 | 393,238.00 |
| Sep 30, 2018 | 393,238.00 |
| Jun 30, 2018 | 707,900.00 |
| Jun 30, 2018 | 707,900.00 |
| Mar 31, 2018 | -84,730.00 |
| Mar 31, 2018 | -84,730.00 |
| Dec 31, 2017 | -100,538.00 |
| Dec 31, 2017 | -100,538.00 |
| Sep 30, 2017 | 283,234.00 |
| Sep 30, 2017 | 283,234.00 |
| Jun 30, 2017 | -89,295.00 |
| Jun 30, 2017 | -89,295.00 |
| Mar 31, 2017 | 30,993.00 |
| Mar 31, 2017 | 30,993.00 |
| Dec 31, 2016 | -69,128.00 |
| Dec 31, 2016 | -69,128.00 |
| Sep 30, 2016 | 111,650.00 |
| Sep 30, 2016 | 111,650.00 |
| Jun 30, 2016 | 25,000.00 |
| Jun 30, 2016 | 25,000.00 |
| Mar 31, 2016 | 25,000.00 |
| Mar 31, 2016 | 25,000.00 |
| Dec 31, 2015 | -23,630.00 |
| Dec 31, 2015 | -23,630.00 |
| Sep 30, 2015 | 84,791.00 |
| Sep 30, 2015 | 84,791.00 |
| Jun 30, 2015 | -17,099.00 |
| Jun 30, 2015 | -17,099.00 |
| Mar 31, 2015 | -9,373.00 |
| Mar 31, 2015 | -9,373.00 |
| Dec 31, 2014 | 9,373.00 |
| Dec 31, 2014 | 9,373.00 |
| Sep 30, 2014 | 14,234.00 |
| Sep 30, 2014 | 14,234.00 |
| Jun 30, 2014 | 6,747.00 |
| Jun 30, 2014 | 6,747.00 |
| Mar 31, 2014 | -8,196.00 |
| Mar 31, 2014 | -8,196.00 |
| Dec 31, 2013 | 20,449.00 |
| Dec 31, 2013 | 20,449.00 |
| Mar 31, 2012 | -34,686.00 |
| Mar 31, 2012 | -34,686.00 |
| Dec 31, 2011 | 25,056.00 |
| Dec 31, 2011 | 25,056.00 |
| Sep 30, 2011 | -22,776.00 |
| Sep 30, 2011 | -22,776.00 |
| Jun 30, 2011 | -16,936.00 |
| Jun 30, 2011 | -16,936.00 |
| Mar 31, 2011 | -12,563.00 |
| Mar 31, 2011 | -12,563.00 |
| Dec 31, 2010 | 38,636.00 |
| Dec 31, 2010 | 38,636.00 |
| Sep 30, 2010 | -18,361.00 |
| Sep 30, 2010 | -18,361.00 |